New vaccine aims to fight breast cancer by training the immune system
⭐️ VACCINE ⭐️
Ongoing
This early-phase study tests a vaccine made from estrogen receptor peptides, combined with immune boosters, in 8 people with ER-positive breast cancer who have completed standard therapy. The goal is to see if the vaccine is safe and can trigger an immune response against cancer …
Phase: PHASE1 • Sponsor: Herbert Lyerly • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC